Avery Rosemary J, Eisenberg Matthew D, Cantor Jonathan H
Department of Policy Analysis and Management, Cornell University, Ithaca, NY 14853, United States.
Department of Health Policy and Management, Johns Hopkins University, Baltimore, MD 21205, United States.
Prev Med. 2017 Apr;97:86-92. doi: 10.1016/j.ypmed.2017.01.008. Epub 2017 Jan 21.
Dietary supplement advertising cannot claim a causal link between the product and the treatment, prevention, or cure of a disease unless manufacturers seek approval from the FDA for a health claim. Manufacturers can make structure-function (S-F) claims without FDA approval linking a supplement to a body function or system using words such as "may help" or "promotes." These S-F claims are examined in this study in order to determine whether they mimic health claims for which the FDA requires stricter scientific evidence. Data include S-F claims in supplement advertisements (N=6179) appearing in US nationally circulated magazines (N=137) from 2003 to 2009. All advertisements were comprehensively coded for S-F claims, seals of approval, and other claims of guarantee. S-F claims associate supplements with a wide variety of health conditions, many of which are serious diseases and/or ailments. A significant number of the specific verbs used in these S-F claims are indicative of disease treatment/cure effects, thereby possibly mimicking health claims to the average consumer. The strength of the clinical associations made are largely unsubstantiated in the medical literature. Claims that a product is "scientifically proven" or "guaranteed" were largely unsubstantiated by clinical literature. Ads carrying externally validating seals of approval were highly prevalent. S-F claims that strongly mimic FDA-prohibited health claims are likely to create confusion in interpretation and possible public health concerns are discussed.
除非制造商寻求美国食品药品监督管理局(FDA)对健康声明的批准,否则膳食补充剂广告不能宣称产品与疾病的治疗、预防或治愈之间存在因果关系。制造商可以在未经FDA批准的情况下做出结构-功能(S-F)声明,将补充剂与身体功能或系统联系起来,使用“可能有助于”或“促进”等词汇。本研究对这些S-F声明进行了审查,以确定它们是否模仿了FDA要求更严格科学证据的健康声明。数据包括2003年至2009年在美国全国发行的杂志(n = 137)上出现的补充剂广告中的S-F声明(n = 6179)。所有广告都针对S-F声明、批准印章和其他保证声明进行了全面编码。S-F声明将补充剂与各种各样的健康状况联系起来,其中许多是严重疾病和/或疾病。这些S-F声明中使用的大量特定动词表明了疾病治疗/治愈效果,从而可能会让普通消费者误以为是健康声明。这些声明所建立的临床关联强度在医学文献中大多未经证实。声称产品“经过科学验证”或“有保证”的说法在临床文献中大多没有依据。带有外部有效批准印章的广告非常普遍。讨论了那些强烈模仿FDA禁止的健康声明的S-F声明可能会在解释上造成混淆以及可能引发的公共卫生问题。